nodes	percent_of_prediction	percent_of_DWPC	metapath
Doxycycline—MMP1—glaucoma	0.669	1	CbGaD
Doxycycline—SLC22A6—Methazolamide—glaucoma	0.0564	0.288	CbGbCtD
Doxycycline—SLC22A6—Acetazolamide—glaucoma	0.0451	0.23	CbGbCtD
Doxycycline—CYP3A4—Pilocarpine—glaucoma	0.0223	0.114	CbGbCtD
Doxycycline—CYP3A4—Brinzolamide—glaucoma	0.0175	0.0892	CbGbCtD
Doxycycline—CYP3A4—Dorzolamide—glaucoma	0.0169	0.0861	CbGbCtD
Doxycycline—CYP3A4—Methazolamide—glaucoma	0.0151	0.0768	CbGbCtD
Doxycycline—CYP3A4—Acetazolamide—glaucoma	0.012	0.0614	CbGbCtD
Doxycycline—CYP3A4—Clonidine—glaucoma	0.0109	0.0555	CbGbCtD
Doxycycline—MMP1—endothelium—glaucoma	0.00388	0.231	CbGeAlD
Doxycycline—MMP7—Syndecan-1-mediated signaling events—COL11A1—glaucoma	0.00349	0.03	CbGpPWpGaD
Doxycycline—SLC22A8—optic choroid—glaucoma	0.00339	0.201	CbGeAlD
Doxycycline—MMP13—Assembly of collagen fibrils and other multimeric structures—COL11A1—glaucoma	0.00281	0.0242	CbGpPWpGaD
Doxycycline—MMP1—Syndecan-1-mediated signaling events—COL11A1—glaucoma	0.00279	0.024	CbGpPWpGaD
Doxycycline—MMP7—Assembly of collagen fibrils and other multimeric structures—COL11A1—glaucoma	0.00271	0.0234	CbGpPWpGaD
Doxycycline—MMP13—connective tissue—glaucoma	0.00261	0.155	CbGeAlD
Doxycycline—MMP13—Assembly of collagen fibrils and other multimeric structures—LOXL1—glaucoma	0.00257	0.0221	CbGpPWpGaD
Doxycycline—MMP7—Assembly of collagen fibrils and other multimeric structures—LOXL1—glaucoma	0.00248	0.0214	CbGpPWpGaD
Doxycycline—MMP8—connective tissue—glaucoma	0.00235	0.14	CbGeAlD
Doxycycline—MMP7—connective tissue—glaucoma	0.00208	0.124	CbGeAlD
Doxycycline—MMP7—p75(NTR)-mediated signaling—NTF4—glaucoma	0.00198	0.017	CbGpPWpGaD
Doxycycline—MMP13—Collagen formation—COL11A1—glaucoma	0.00191	0.0165	CbGpPWpGaD
Doxycycline—MMP7—Collagen formation—COL11A1—glaucoma	0.00185	0.0159	CbGpPWpGaD
Doxycycline—MMP1—connective tissue—glaucoma	0.00183	0.109	CbGeAlD
Doxycycline—MMP13—Collagen formation—LOXL1—glaucoma	0.00175	0.0151	CbGpPWpGaD
Doxycycline—MMP7—Collagen formation—LOXL1—glaucoma	0.00169	0.0146	CbGpPWpGaD
Doxycycline—MMP8—Extracellular matrix organization—LTBP3—glaucoma	0.00155	0.0134	CbGpPWpGaD
Doxycycline—MMP8—Extracellular matrix organization—LTBP2—glaucoma	0.00155	0.0134	CbGpPWpGaD
Doxycycline—MMP8—Matrix Metalloproteinases—MMP1—glaucoma	0.00138	0.0118	CbGpPWpGaD
Doxycycline—MMP8—Activation of Matrix Metalloproteinases—MMP1—glaucoma	0.00131	0.0113	CbGpPWpGaD
Doxycycline—MMP8—Collagen degradation—MMP1—glaucoma	0.00114	0.00981	CbGpPWpGaD
Doxycycline—MMP13—Extracellular matrix organization—LTBP3—glaucoma	0.00113	0.00976	CbGpPWpGaD
Doxycycline—MMP13—Extracellular matrix organization—LTBP2—glaucoma	0.00113	0.00976	CbGpPWpGaD
Doxycycline—MMP7—Posttranslational regulation of adherens junction stability and dissassembly—NTRK2—glaucoma	0.0011	0.00946	CbGpPWpGaD
Doxycycline—MMP7—Extracellular matrix organization—LTBP3—glaucoma	0.0011	0.00943	CbGpPWpGaD
Doxycycline—MMP7—Extracellular matrix organization—LTBP2—glaucoma	0.0011	0.00943	CbGpPWpGaD
Doxycycline—MMP8—Matrix Metalloproteinases—MMP2—glaucoma	0.00107	0.00917	CbGpPWpGaD
Doxycycline—MMP8—Extracellular matrix organization—COL11A1—glaucoma	0.00105	0.00904	CbGpPWpGaD
Doxycycline—MMP8—Activation of Matrix Metalloproteinases—MMP2—glaucoma	0.00101	0.00871	CbGpPWpGaD
Doxycycline—MMP13—Matrix Metalloproteinases—MMP1—glaucoma	0.001	0.00864	CbGpPWpGaD
Doxycycline—Minocycline—VEGFA—glaucoma	0.000992	0.508	CrCbGaD
Doxycycline—MMP7—Matrix Metalloproteinases—MMP1—glaucoma	0.00097	0.00835	CbGpPWpGaD
Doxycycline—MMP8—Extracellular matrix organization—LOXL1—glaucoma	0.00096	0.00827	CbGpPWpGaD
Doxycycline—Minocycline—MMP9—glaucoma	0.000959	0.492	CrCbGaD
Doxycycline—MMP13—Activation of Matrix Metalloproteinases—MMP1—glaucoma	0.000954	0.00821	CbGpPWpGaD
Doxycycline—MMP13—Endochondral Ossification—TGFB2—glaucoma	0.000948	0.00816	CbGpPWpGaD
Doxycycline—MMP7—Activation of Matrix Metalloproteinases—MMP1—glaucoma	0.000921	0.00793	CbGpPWpGaD
Doxycycline—MMP8—Collagen degradation—MMP2—glaucoma	0.000882	0.00759	CbGpPWpGaD
Doxycycline—MMP1—Extracellular matrix organization—LTBP3—glaucoma	0.000876	0.00754	CbGpPWpGaD
Doxycycline—MMP1—Extracellular matrix organization—LTBP2—glaucoma	0.000876	0.00754	CbGpPWpGaD
Doxycycline—MMP1—Basigin interactions—CAV1—glaucoma	0.00086	0.0074	CbGpPWpGaD
Doxycycline—MMP1—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—PTGS2—glaucoma	0.00085	0.00732	CbGpPWpGaD
Doxycycline—MMP8—Extracellular matrix organization—ELN—glaucoma	0.00084	0.00723	CbGpPWpGaD
Doxycycline—MMP13—Collagen degradation—MMP1—glaucoma	0.000831	0.00715	CbGpPWpGaD
Doxycycline—MMP7—Posttranslational regulation of adherens junction stability and dissassembly—BDNF—glaucoma	0.00082	0.00706	CbGpPWpGaD
Doxycycline—MMP7—Collagen degradation—MMP1—glaucoma	0.000803	0.00691	CbGpPWpGaD
Doxycycline—MMP7—Syndecan-1-mediated signaling events—MMP1—glaucoma	0.000803	0.00691	CbGpPWpGaD
Doxycycline—MMP8—Matrix Metalloproteinases—MMP9—glaucoma	0.000801	0.00689	CbGpPWpGaD
Doxycycline—MMP1—Regulation of IGF Activity by IGFBP—MMP2—glaucoma	0.000798	0.00687	CbGpPWpGaD
Doxycycline—MMP13—Matrix Metalloproteinases—MMP2—glaucoma	0.000777	0.00669	CbGpPWpGaD
Doxycycline—MMP13—Extracellular matrix organization—COL11A1—glaucoma	0.000766	0.0066	CbGpPWpGaD
Doxycycline—MMP8—Activation of Matrix Metalloproteinases—MMP9—glaucoma	0.00076	0.00654	CbGpPWpGaD
Doxycycline—MMP7—Matrix Metalloproteinases—MMP2—glaucoma	0.00075	0.00646	CbGpPWpGaD
Doxycycline—MMP7—Extracellular matrix organization—COL11A1—glaucoma	0.00074	0.00637	CbGpPWpGaD
Doxycycline—MMP13—Activation of Matrix Metalloproteinases—MMP2—glaucoma	0.000738	0.00635	CbGpPWpGaD
Doxycycline—MMP7—Activation of Matrix Metalloproteinases—MMP2—glaucoma	0.000713	0.00614	CbGpPWpGaD
Doxycycline—MMP1—Integrated Cancer Pathway—CDKN2B—glaucoma	0.000708	0.00609	CbGpPWpGaD
Doxycycline—MMP7—p75(NTR)-mediated signaling—NGFR—glaucoma	0.000705	0.00607	CbGpPWpGaD
Doxycycline—MMP13—AGE/RAGE pathway—SOD1—glaucoma	0.000701	0.00603	CbGpPWpGaD
Doxycycline—MMP13—Extracellular matrix organization—LOXL1—glaucoma	0.000701	0.00603	CbGpPWpGaD
Doxycycline—MMP13—Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling—FN1—glaucoma	0.0007	0.00603	CbGpPWpGaD
Doxycycline—SLC22A8—eye—glaucoma	0.000681	0.0405	CbGeAlD
Doxycycline—MMP7—AGE/RAGE pathway—SOD1—glaucoma	0.000677	0.00583	CbGpPWpGaD
Doxycycline—MMP7—Extracellular matrix organization—LOXL1—glaucoma	0.000677	0.00583	CbGpPWpGaD
Doxycycline—MMP7—p75(NTR)-mediated signaling—NTRK1—glaucoma	0.00067	0.00577	CbGpPWpGaD
Doxycycline—MMP1—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—VEGFA—glaucoma	0.000669	0.00576	CbGpPWpGaD
Doxycycline—MMP8—Collagen degradation—MMP9—glaucoma	0.000663	0.0057	CbGpPWpGaD
Doxycycline—MMP13—Collagen degradation—MMP2—glaucoma	0.000643	0.00554	CbGpPWpGaD
Doxycycline—MMP7—Collagen degradation—MMP2—glaucoma	0.000621	0.00535	CbGpPWpGaD
Doxycycline—MMP8—Matrix Metalloproteinases—TNF—glaucoma	0.000616	0.0053	CbGpPWpGaD
Doxycycline—MMP7—p75(NTR)-mediated signaling—BDNF—glaucoma	0.000614	0.00528	CbGpPWpGaD
Doxycycline—MMP13—Extracellular matrix organization—ELN—glaucoma	0.000612	0.00527	CbGpPWpGaD
Doxycycline—MMP1—Matrix Metalloproteinases—MMP2—glaucoma	0.0006	0.00516	CbGpPWpGaD
Doxycycline—MMP1—Extracellular matrix organization—COL11A1—glaucoma	0.000591	0.00509	CbGpPWpGaD
Doxycycline—MMP7—Extracellular matrix organization—ELN—glaucoma	0.000591	0.00509	CbGpPWpGaD
Doxycycline—MMP13—Matrix Metalloproteinases—MMP9—glaucoma	0.000584	0.00503	CbGpPWpGaD
Doxycycline—MMP8—Degradation of the extracellular matrix—MMP1—glaucoma	0.000577	0.00496	CbGpPWpGaD
Doxycycline—MMP1—Activation of Matrix Metalloproteinases—MMP2—glaucoma	0.00057	0.0049	CbGpPWpGaD
Doxycycline—MMP7—Matrix Metalloproteinases—MMP9—glaucoma	0.000564	0.00486	CbGpPWpGaD
Doxycycline—MMP13—Activation of Matrix Metalloproteinases—MMP9—glaucoma	0.000555	0.00477	CbGpPWpGaD
Doxycycline—MMP7—p75(NTR)-mediated signaling—NGF—glaucoma	0.000545	0.00469	CbGpPWpGaD
Doxycycline—MMP1—Extracellular matrix organization—LOXL1—glaucoma	0.000541	0.00466	CbGpPWpGaD
Doxycycline—MMP13—Oncostatin M Signaling Pathway—MMP1—glaucoma	0.000541	0.00466	CbGpPWpGaD
Doxycycline—MMP7—Activation of Matrix Metalloproteinases—MMP9—glaucoma	0.000536	0.00461	CbGpPWpGaD
Doxycycline—MMP1—Bladder Cancer—CDKN2A—glaucoma	0.000535	0.00461	CbGpPWpGaD
Doxycycline—SLC22A11—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC6A13—glaucoma	0.000515	0.00443	CbGpPWpGaD
Doxycycline—MMP1—Integrated Cancer Pathway—BAD—glaucoma	0.000515	0.00443	CbGpPWpGaD
Doxycycline—MMP1—Endothelins—EDN1—glaucoma	0.000509	0.00439	CbGpPWpGaD
Doxycycline—MMP1—Validated transcriptional targets of AP1 family members Fra1 and Fra2—MMP2—glaucoma	0.000507	0.00437	CbGpPWpGaD
Doxycycline—MMP7—Wnt Signaling Pathway and Pluripotency—CCND2—glaucoma	0.000504	0.00434	CbGpPWpGaD
Doxycycline—MMP1—Collagen degradation—MMP2—glaucoma	0.000497	0.00427	CbGpPWpGaD
Doxycycline—MMP13—Collagen degradation—MMP9—glaucoma	0.000483	0.00416	CbGpPWpGaD
Doxycycline—MMP1—Validated transcriptional targets of AP1 family members Fra1 and Fra2—NOS3—glaucoma	0.000475	0.00409	CbGpPWpGaD
Doxycycline—MMP1—Extracellular matrix organization—ELN—glaucoma	0.000473	0.00407	CbGpPWpGaD
Doxycycline—MMP1—AP-1 transcription factor network—EDN1—glaucoma	0.000468	0.00403	CbGpPWpGaD
Doxycycline—MMP7—Collagen degradation—MMP9—glaucoma	0.000467	0.00402	CbGpPWpGaD
Doxycycline—MMP7—Syndecan-1-mediated signaling events—MMP9—glaucoma	0.000467	0.00402	CbGpPWpGaD
Doxycycline—MMP1—Validated transcriptional targets of AP1 family members Fra1 and Fra2—CDKN2A—glaucoma	0.000465	0.004	CbGpPWpGaD
Doxycycline—MMP1—Matrix Metalloproteinases—MMP9—glaucoma	0.000451	0.00388	CbGpPWpGaD
Doxycycline—MMP13—Matrix Metalloproteinases—TNF—glaucoma	0.000449	0.00387	CbGpPWpGaD
Doxycycline—MMP7—p75(NTR)-mediated signaling—BAD—glaucoma	0.000449	0.00387	CbGpPWpGaD
Doxycycline—MMP8—Degradation of the extracellular matrix—MMP2—glaucoma	0.000446	0.00384	CbGpPWpGaD
Doxycycline—MMP13—Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling—MMP9—glaucoma	0.000446	0.00384	CbGpPWpGaD
Doxycycline—MMP7—Matrix Metalloproteinases—TNF—glaucoma	0.000434	0.00374	CbGpPWpGaD
Doxycycline—MMP1—AP-1 transcription factor network—NR3C1—glaucoma	0.000428	0.00369	CbGpPWpGaD
Doxycycline—MMP1—Activation of Matrix Metalloproteinases—MMP9—glaucoma	0.000428	0.00369	CbGpPWpGaD
Doxycycline—MMP13—Degradation of the extracellular matrix—MMP1—glaucoma	0.000421	0.00362	CbGpPWpGaD
Doxycycline—MMP8—Extracellular matrix organization—TGFB2—glaucoma	0.000418	0.0036	CbGpPWpGaD
Doxycycline—MMP13—AGE/RAGE pathway—MMP2—glaucoma	0.000414	0.00356	CbGpPWpGaD
Doxycycline—MMP7—Degradation of the extracellular matrix—MMP1—glaucoma	0.000406	0.0035	CbGpPWpGaD
Doxycycline—MMP7—AGE/RAGE pathway—MMP2—glaucoma	0.000399	0.00344	CbGpPWpGaD
Doxycycline—MMP1—Bladder Cancer—VEGFA—glaucoma	0.000394	0.0034	CbGpPWpGaD
Doxycycline—SLC22A8—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC6A13—glaucoma	0.000393	0.00338	CbGpPWpGaD
Doxycycline—MMP13—AGE/RAGE pathway—NOS3—glaucoma	0.000387	0.00333	CbGpPWpGaD
Doxycycline—MMP1—Validated transcriptional targets of AP1 family members Fra1 and Fra2—MMP9—glaucoma	0.000381	0.00328	CbGpPWpGaD
Doxycycline—MMP1—Glucocorticoid receptor regulatory network—NR3C1—glaucoma	0.000377	0.00325	CbGpPWpGaD
Doxycycline—SLC22A11—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC6A1—glaucoma	0.000377	0.00324	CbGpPWpGaD
Doxycycline—MMP13—Assembly of collagen fibrils and other multimeric structures—MMP9—glaucoma	0.000376	0.00324	CbGpPWpGaD
Doxycycline—MMP7—AGE/RAGE pathway—NOS3—glaucoma	0.000374	0.00322	CbGpPWpGaD
Doxycycline—MMP1—Collagen degradation—MMP9—glaucoma	0.000373	0.00321	CbGpPWpGaD
Doxycycline—MMP1—Syndecan-1-mediated signaling events—MMP9—glaucoma	0.000373	0.00321	CbGpPWpGaD
Doxycycline—MMP1—Metabolism of proteins—DHPS—glaucoma	0.000365	0.00314	CbGpPWpGaD
Doxycycline—MMP7—Assembly of collagen fibrils and other multimeric structures—MMP9—glaucoma	0.000363	0.00313	CbGpPWpGaD
Doxycycline—MMP1—Integrated Cancer Pathway—CDKN1B—glaucoma	0.000358	0.00309	CbGpPWpGaD
Doxycycline—SLC22A11—SLC-mediated transmembrane transport—SLC4A4—glaucoma	0.000351	0.00302	CbGpPWpGaD
Doxycycline—MMP1—Matrix Metalloproteinases—TNF—glaucoma	0.000347	0.00299	CbGpPWpGaD
Doxycycline—MMP13—Oncostatin M Signaling Pathway—CDKN1B—glaucoma	0.00034	0.00292	CbGpPWpGaD
Doxycycline—MMP8—Degradation of the extracellular matrix—MMP9—glaucoma	0.000335	0.00289	CbGpPWpGaD
Doxycycline—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC6A13—glaucoma	0.000328	0.00282	CbGpPWpGaD
Doxycycline—MMP13—Degradation of the extracellular matrix—MMP2—glaucoma	0.000326	0.0028	CbGpPWpGaD
Doxycycline—MMP13—Endochondral Ossification—MMP9—glaucoma	0.000319	0.00274	CbGpPWpGaD
Doxycycline—MMP7—Degradation of the extracellular matrix—MMP2—glaucoma	0.000314	0.00271	CbGpPWpGaD
Doxycycline—CYP3A4—Benzo(a)pyrene metabolism—CYP1B1—glaucoma	0.000313	0.00269	CbGpPWpGaD
Doxycycline—MMP13—AGE/RAGE pathway—MMP9—glaucoma	0.000311	0.00268	CbGpPWpGaD
Doxycycline—CYP3A4—Aflatoxin B1 metabolism—GSTM1—glaucoma	0.000306	0.00263	CbGpPWpGaD
Doxycycline—MMP13—Extracellular matrix organization—TGFB2—glaucoma	0.000305	0.00263	CbGpPWpGaD
Doxycycline—MMP7—AGE/RAGE pathway—MMP9—glaucoma	0.0003	0.00258	CbGpPWpGaD
Doxycycline—MMP1—Bladder Cancer—TP53—glaucoma	0.000298	0.00257	CbGpPWpGaD
Doxycycline—MMP7—Extracellular matrix organization—TGFB2—glaucoma	0.000295	0.00254	CbGpPWpGaD
Doxycycline—MMP1—TGF-beta Signaling Pathway—CDKN2B—glaucoma	0.000294	0.00253	CbGpPWpGaD
Doxycycline—SLC22A8—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC6A1—glaucoma	0.000287	0.00247	CbGpPWpGaD
Doxycycline—MMP13—Endochondral Ossification—VEGFA—glaucoma	0.000286	0.00246	CbGpPWpGaD
Doxycycline—MMP1—Cell surface interactions at the vascular wall—CAV1—glaucoma	0.000286	0.00246	CbGpPWpGaD
Doxycycline—MMP13—Oncostatin M Signaling Pathway—VEGFA—glaucoma	0.000283	0.00243	CbGpPWpGaD
Doxycycline—MMP1—AP-1 transcription factor network—CDKN2A—glaucoma	0.000279	0.0024	CbGpPWpGaD
Doxycycline—MMP1—Cell surface interactions at the vascular wall—FN1—glaucoma	0.000272	0.00234	CbGpPWpGaD
Doxycycline—SLC22A8—SLC-mediated transmembrane transport—SLC4A4—glaucoma	0.000267	0.0023	CbGpPWpGaD
Doxycycline—SLC22A11—Transmembrane transport of small molecules—PEX19—glaucoma	0.000264	0.00227	CbGpPWpGaD
Doxycycline—MMP1—Oncostatin M Signaling Pathway—CDKN1B—glaucoma	0.000262	0.00226	CbGpPWpGaD
Doxycycline—MMP13—Collagen formation—MMP9—glaucoma	0.000256	0.00221	CbGpPWpGaD
Doxycycline—MMP1—Degradation of the extracellular matrix—MMP2—glaucoma	0.000251	0.00216	CbGpPWpGaD
Doxycycline—MMP7—Collagen formation—MMP9—glaucoma	0.000247	0.00213	CbGpPWpGaD
Doxycycline—MMP1—AP-1 transcription factor network—CDKN1B—glaucoma	0.000247	0.00213	CbGpPWpGaD
Doxycycline—MMP13—Degradation of the extracellular matrix—MMP9—glaucoma	0.000245	0.00211	CbGpPWpGaD
Doxycycline—MMP8—Extracellular matrix organization—MMP1—glaucoma	0.000242	0.00208	CbGpPWpGaD
Doxycycline—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC6A1—glaucoma	0.00024	0.00207	CbGpPWpGaD
Doxycycline—MMP7—Degradation of the extracellular matrix—MMP9—glaucoma	0.000236	0.00203	CbGpPWpGaD
Doxycycline—MMP1—Extracellular matrix organization—TGFB2—glaucoma	0.000235	0.00203	CbGpPWpGaD
Doxycycline—SLC22A11—SLC-mediated transmembrane transport—SLC6A13—glaucoma	0.000234	0.00201	CbGpPWpGaD
Doxycycline—MMP1—AP-1 transcription factor network—MMP9—glaucoma	0.000229	0.00197	CbGpPWpGaD
Doxycycline—MMP1—Metabolism of proteins—CTSA—glaucoma	0.000228	0.00196	CbGpPWpGaD
Doxycycline—MMP1—TGF-beta Signaling Pathway—CAV1—glaucoma	0.000227	0.00196	CbGpPWpGaD
Doxycycline—MMP1—Integrated Cancer Pathway—TP53—glaucoma	0.000225	0.00194	CbGpPWpGaD
Doxycycline—SLC22A6—SLC-mediated transmembrane transport—SLC4A4—glaucoma	0.000223	0.00192	CbGpPWpGaD
Doxycycline—MMP8—Extracellular matrix organization—FN1—glaucoma	0.00022	0.0019	CbGpPWpGaD
Doxycycline—MMP1—Oncostatin M Signaling Pathway—VEGFA—glaucoma	0.000218	0.00188	CbGpPWpGaD
Doxycycline—MMP1—TGF-beta Signaling Pathway—FN1—glaucoma	0.000216	0.00186	CbGpPWpGaD
Doxycycline—MMP13—Oncostatin M Signaling Pathway—TP53—glaucoma	0.000213	0.00184	CbGpPWpGaD
Doxycycline—MMP1—Metabolism of proteins—ACE2—glaucoma	0.00021	0.0018	CbGpPWpGaD
Doxycycline—SLC22A8—Transmembrane transport of small molecules—PEX19—glaucoma	0.000201	0.00173	CbGpPWpGaD
Doxycycline—MMP7—p75(NTR)-mediated signaling—TP53—glaucoma	0.000197	0.00169	CbGpPWpGaD
Doxycycline—MMP1—Integrated Breast Cancer Pathway—BAD—glaucoma	0.000192	0.00165	CbGpPWpGaD
Doxycycline—MMP1—Degradation of the extracellular matrix—MMP9—glaucoma	0.000189	0.00163	CbGpPWpGaD
Doxycycline—MMP8—Extracellular matrix organization—MMP2—glaucoma	0.000187	0.00161	CbGpPWpGaD
Doxycycline—CYP3A4—Estrogen metabolism—CYP1B1—glaucoma	0.00018	0.00155	CbGpPWpGaD
Doxycycline—SLC22A8—SLC-mediated transmembrane transport—SLC6A13—glaucoma	0.000178	0.00154	CbGpPWpGaD
Doxycycline—SLC22A11—Transmembrane transport of small molecules—SLC4A4—glaucoma	0.000178	0.00153	CbGpPWpGaD
Doxycycline—MMP13—Extracellular matrix organization—MMP1—glaucoma	0.000176	0.00152	CbGpPWpGaD
Doxycycline—SLC22A11—SLC-mediated transmembrane transport—SLC6A1—glaucoma	0.000171	0.00147	CbGpPWpGaD
Doxycycline—MMP7—Extracellular matrix organization—MMP1—glaucoma	0.00017	0.00147	CbGpPWpGaD
Doxycycline—SLC22A6—Transmembrane transport of small molecules—PEX19—glaucoma	0.000168	0.00145	CbGpPWpGaD
Doxycycline—MMP1—Oncostatin M Signaling Pathway—TP53—glaucoma	0.000165	0.00142	CbGpPWpGaD
Doxycycline—MMP13—Extracellular matrix organization—FN1—glaucoma	0.000161	0.00138	CbGpPWpGaD
Doxycycline—CYP3A4—Tamoxifen metabolism—CYP1B1—glaucoma	0.000159	0.00137	CbGpPWpGaD
Doxycycline—MMP7—Extracellular matrix organization—FN1—glaucoma	0.000155	0.00134	CbGpPWpGaD
Doxycycline—MMP1—AP-1 transcription factor network—TP53—glaucoma	0.000155	0.00134	CbGpPWpGaD
Doxycycline—SLC22A6—SLC-mediated transmembrane transport—SLC6A13—glaucoma	0.000149	0.00128	CbGpPWpGaD
Doxycycline—MMP7—Wnt Signaling Pathway and Pluripotency—TP53—glaucoma	0.000144	0.00124	CbGpPWpGaD
Doxycycline—CYP3A4—Estrogen metabolism—GSTM1—glaucoma	0.000144	0.00124	CbGpPWpGaD
Doxycycline—MMP8—Extracellular matrix organization—MMP9—glaucoma	0.000141	0.00121	CbGpPWpGaD
Doxycycline—MMP1—Hemostasis—TGFB2—glaucoma	0.00014	0.0012	CbGpPWpGaD
Doxycycline—MMP1—Glucocorticoid receptor regulatory network—TP53—glaucoma	0.000137	0.00118	CbGpPWpGaD
Doxycycline—MMP13—Extracellular matrix organization—MMP2—glaucoma	0.000136	0.00117	CbGpPWpGaD
Doxycycline—SLC22A8—Transmembrane transport of small molecules—SLC4A4—glaucoma	0.000136	0.00117	CbGpPWpGaD
Doxycycline—MMP7—Extracellular matrix organization—MMP2—glaucoma	0.000132	0.00113	CbGpPWpGaD
Doxycycline—SLC22A8—SLC-mediated transmembrane transport—SLC6A1—glaucoma	0.000131	0.00112	CbGpPWpGaD
Doxycycline—MMP1—Extracellular matrix organization—FN1—glaucoma	0.000124	0.00107	CbGpPWpGaD
Doxycycline—SLC22A11—Transmembrane transport of small molecules—SLC6A13—glaucoma	0.000119	0.00102	CbGpPWpGaD
Doxycycline—SLC22A6—Transmembrane transport of small molecules—SLC4A4—glaucoma	0.000113	0.000976	CbGpPWpGaD
Doxycycline—MMP1—Metabolism of proteins—PAX6—glaucoma	0.000112	0.000962	CbGpPWpGaD
Doxycycline—MMP1—Integrated Breast Cancer Pathway—VEGFA—glaucoma	0.000111	0.000957	CbGpPWpGaD
Doxycycline—SLC22A6—SLC-mediated transmembrane transport—SLC6A1—glaucoma	0.000109	0.000938	CbGpPWpGaD
Doxycycline—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCA1—glaucoma	0.000108	0.000929	CbGpPWpGaD
Doxycycline—MMP1—Hemostasis—SOD1—glaucoma	0.000106	0.000913	CbGpPWpGaD
Doxycycline—MMP1—Extracellular matrix organization—MMP2—glaucoma	0.000105	0.000907	CbGpPWpGaD
Doxycycline—MMP13—Extracellular matrix organization—MMP9—glaucoma	0.000103	0.000883	CbGpPWpGaD
Doxycycline—MMP7—Extracellular matrix organization—MMP9—glaucoma	9.9e-05	0.000852	CbGpPWpGaD
Doxycycline—MMP1—TGF-beta Signaling Pathway—TP53—glaucoma	9.35e-05	0.000805	CbGpPWpGaD
Doxycycline—SLC22A8—Transmembrane transport of small molecules—SLC6A13—glaucoma	9.07e-05	0.000781	CbGpPWpGaD
Doxycycline—SLC22A11—Transmembrane transport of small molecules—SLC6A1—glaucoma	8.7e-05	0.000749	CbGpPWpGaD
Doxycycline—CYP3A4—Tryptophan metabolism—CYP1B1—glaucoma	8.47e-05	0.00073	CbGpPWpGaD
Doxycycline—MMP1—Integrated Breast Cancer Pathway—TP53—glaucoma	8.4e-05	0.000723	CbGpPWpGaD
Doxycycline—MMP1—Extracellular matrix organization—MMP9—glaucoma	7.92e-05	0.000681	CbGpPWpGaD
Doxycycline—MMP1—Hemostasis—CAV1—glaucoma	7.75e-05	0.000668	CbGpPWpGaD
Doxycycline—SLC22A6—Transmembrane transport of small molecules—SLC6A13—glaucoma	7.57e-05	0.000652	CbGpPWpGaD
Doxycycline—MMP1—Hemostasis—FN1—glaucoma	7.38e-05	0.000635	CbGpPWpGaD
Doxycycline—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1B1—glaucoma	6.85e-05	0.00059	CbGpPWpGaD
Doxycycline—CYP3A4—Oxidation by Cytochrome P450—CYP1B1—glaucoma	6.76e-05	0.000582	CbGpPWpGaD
Doxycycline—SLC22A8—Transmembrane transport of small molecules—SLC6A1—glaucoma	6.64e-05	0.000571	CbGpPWpGaD
Doxycycline—MMP1—Hemostasis—NOS3—glaucoma	5.86e-05	0.000505	CbGpPWpGaD
Doxycycline—CYP3A4—Phase 1 - Functionalization of compounds—CYP1B1—glaucoma	5.55e-05	0.000478	CbGpPWpGaD
Doxycycline—SLC22A6—Transmembrane transport of small molecules—SLC6A1—glaucoma	5.54e-05	0.000477	CbGpPWpGaD
Doxycycline—MMP1—Metabolism of proteins—MMP2—glaucoma	4.92e-05	0.000424	CbGpPWpGaD
Doxycycline—MMP1—Hemostasis—VEGFA—glaucoma	4.22e-05	0.000364	CbGpPWpGaD
Doxycycline—CYP3A4—Biological oxidations—GSTT1—glaucoma	3.7e-05	0.000319	CbGpPWpGaD
Doxycycline—MMP1—Hemostasis—TP53—glaucoma	3.19e-05	0.000275	CbGpPWpGaD
Doxycycline—CYP3A4—Biological oxidations—CYP1B1—glaucoma	2.95e-05	0.000254	CbGpPWpGaD
Doxycycline—CYP3A4—Metapathway biotransformation—CYP1B1—glaucoma	2.91e-05	0.000251	CbGpPWpGaD
Doxycycline—CYP3A4—Metabolism—CA5A—glaucoma	2.6e-05	0.000223	CbGpPWpGaD
Doxycycline—CYP3A4—Metabolism—NARFL—glaucoma	2.6e-05	0.000223	CbGpPWpGaD
Doxycycline—CYP3A4—Biological oxidations—GSTM1—glaucoma	2.36e-05	0.000203	CbGpPWpGaD
Doxycycline—CYP3A4—Metapathway biotransformation—GSTM1—glaucoma	2.33e-05	0.0002	CbGpPWpGaD
Doxycycline—CYP3A4—Metabolism—CA1—glaucoma	1.27e-05	0.000109	CbGpPWpGaD
Doxycycline—CYP3A4—Metabolism—CTSA—glaucoma	1.23e-05	0.000106	CbGpPWpGaD
Doxycycline—CYP3A4—Metabolism—CA2—glaucoma	1.16e-05	9.98e-05	CbGpPWpGaD
Doxycycline—CYP3A4—Metabolism—TXN—glaucoma	8.17e-06	7.03e-05	CbGpPWpGaD
Doxycycline—CYP3A4—Metabolism—GSTT1—glaucoma	6.33e-06	5.45e-05	CbGpPWpGaD
Doxycycline—CYP3A4—Metabolism—ABCA1—glaucoma	5.05e-06	4.34e-05	CbGpPWpGaD
Doxycycline—CYP3A4—Metabolism—CYP1B1—glaucoma	5.05e-06	4.34e-05	CbGpPWpGaD
Doxycycline—CYP3A4—Metabolism—GSTM1—glaucoma	4.03e-06	3.47e-05	CbGpPWpGaD
Doxycycline—CYP3A4—Metabolism—MTHFR—glaucoma	3.57e-06	3.07e-05	CbGpPWpGaD
Doxycycline—CYP3A4—Metabolism—APOE—glaucoma	3.32e-06	2.86e-05	CbGpPWpGaD
Doxycycline—CYP3A4—Metabolism—CAV1—glaucoma	3.29e-06	2.83e-05	CbGpPWpGaD
Doxycycline—CYP3A4—Metabolism—NOS3—glaucoma	2.49e-06	2.14e-05	CbGpPWpGaD
Doxycycline—CYP3A4—Metabolism—PTGS2—glaucoma	2.27e-06	1.96e-05	CbGpPWpGaD
